Extended Release Formulations of Oxybutynin and Tolterodine for the Treatment of Overactive Bladder: A German Health Economic Analysis

El-Hadi W1, Getsios D1, Caro J J1, Duchesne I2, Feng W2, Dubois D2 1. Caro Research Institute, 2. Johnson & Johnson Pharmaceutical Services LLC

Abstract Category

Epidemiology & Outcomes Research

Abstract 409
Read By Title:
Scientific Non Discussion Abstract Session 21